Q2 2026 saw a return to organic revenue growth, strong margin expansion, and 53% non-GAAP EPS growth, driven by robust demand in deep tech and scientific instruments. Cost-saving actions are on track, with FY 2026 guidance reaffirmed for revenue and double-digit EPS growth.Based on Bruker Corporatiā¦
Q2 2026 saw a return to organic revenue growth, strong margin expansion, and 53% non-GAAP EPS growth, driven by robust demand in deep tech and scientific instruments. Cost-saving actions are on track, with FY 2026 guidance reaffirmed for revenue and double-digit EPS growth.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.